Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial

INTRODUCTION: The Chinese herbal compound formula, Shenqisuxin granule (SQSX), promotes neovascularization and prevents in-stent restenosis in modern pharmaceutical studies and is expected to provide an effective strategy for non-ST-segment elevation acute coronary syndrome (NSTEACS). Thus, this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaoping, Guo, Ming, Shi, Shihua, Shi, Shengnan, Deng, Yanping, Wang, Shenglan, Wang, Yabing, Wang, Peili, Chen, Keji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218484/
https://www.ncbi.nlm.nih.gov/pubmed/35757330
http://dx.doi.org/10.3389/fcvm.2022.888724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218484/
https://www.ncbi.nlm.nih.gov/pubmed/35757330
http://dx.doi.org/10.3389/fcvm.2022.888724

Ejemplares similares